Prognostic Value of Fibrinogen-to-Albumin Ratio in Coronary Three-Vessel Disease

Abstract

Xinsheng Li,1,* Zhongzhen Wang,1,* Yifan Zhu,2 Haichen Lv,1 Xuchen Zhou,1 Hao Zhu,1 Jinqiu Liu,1 Lei Guo1 1Department of Cardiology, the First Affiliated Hospital of Dalian Medical University, Dalian City, People’s Republic of China; 2Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang City, People’s Republic of China*These authors contributed equally to this workCorrespondence: Lei Guo; Jinqiu Liu, Department of Cardiology, the First Affiliated Hospital of Dalian Medical University, 222 Zhongshan Road, Dalian City, 116011, People’s Republic of China, Tel [phone], Email [email protected]; [email protected]: To investigate the prognostic value of fibrinogen-to-albumin ratio (FAR) in the adverse outcomes of patients with coronary three-vessel disease (TVD).Methods: A total of 4061 patients with TVD between 2013 and 2018 were analyzed in this retrospective cohort study. The best cut‑off value of the FAR determined by receiver operating characteristic (ROC) curve analysis was 0.084. 2782 (68.5%) patients were in the low FAR group (FAR

Keywords

• three-vessel disease
• fibrinogen-to-albumin ratio
• mortality
• major adverse cardiac and cerebrovascular events
• coronary artery disease